CASI Pharmaceuticals
CASI
CASI
23 hedge funds and large institutions have $1.94M invested in CASI Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
23
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$614K | |
| 2 | +$62.3K | |
| 3 | +$45.3K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$38K |
| 5 |
Renaissance Technologies
New York
|
+$22K |
Top Sellers
| 1 | -$139K | |
| 2 | -$63.3K | |
| 3 | -$16.5K | |
| 4 |
CFM
Catalyst Funds Management
Sydney NSW,
Australia
|
-$9.91K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.8K |